| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 |
| filingDate |
2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e151fc8af5d47822fede24acd4e213d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d04e00953e8e102b3983873d4cf895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c219df41c51f718fdbe0da3b3bc044 |
| publicationDate |
2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MA-41574-A1 |
| titleOfInvention |
Pde9 inhibitors having an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases |
| abstract |
The present invention relates to inhibitors of pde9 and their use for the treatment of benign prostatic hyperplasia and sickle cell disease. |
| priorityDate |
2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |